By Par Pharmaceutical Inc | Last revised: 1 January 2012
Methimazole is indicated: In patients with Graves’ disease with hyperthyroidism or toxic multinodular goiter for whom surgery or radioactive iodine therapy is not an appropriate treatment option. To ameliorate symptoms of hyperthyroidism in…
By Mylan Pharmaceuticals Inc. | Last revised: 1 January 2012
Pantoprazole sodium delayed-release tablets are indicated for: Pantoprazole is a proton pump inhibitor indicated for the following: Short-Term Treatment of Erosive Esophagitis Associated with Gastroesophageal Reflux Disease (GERD). (1.1) Maintenance…
By Qualitest Pharmaceuticals | Last revised: 1 January 2012
Valproic acid oral solution USP is indicated as monotherapy and adjunctive therapy in the treatment of patients with complex partial seizures that occur either in isolation or in association with other types of seizures. Valproic acid oral solution…
By ECR Pharmaceuticals Co., Inc. | Last revised: 1 January 2012
ZOLVIT® is indicated for the relief of moderate to moderately severe pain. CONTRAINDICATIONS: This product should not be administered to patients who have previously exhibited hypersensitivity to hydrocodone, acetaminophen, or any other component…
By Novartis Pharmaceuticals Corporation | Last revised: 1 January 2012
Desferal is indicated for the treatment of acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias. Acute Iron Intoxication. Desferal is an adjunct to, and not a substitute for, standard measures used in treating…